semaglutide vs tirzepatide clinical comparison versus Once Weekly in Patients with Type 2 Diabetes Cardiovascular outcomes of semaglutide and

Sobos semaglutide page explains that semaglutide acts as a GLP-1 agonist and may help reduce appetite, slow gastric emptying, promote fullness, and support weight loss more effectively than diet and exercise alone for some patients

Sobos article on GLP-1 weight loss and muscle loss explains why the quality of weight loss matters as much as the number of pounds lost

Efficacy Research studies have demonstrated the efficacy of both Tirzepatide and Semaglutide in promoting weight loss

A provider should review: Current dose Side effects Weight loss progress Nutrition intake Hydration Lab results Medical history Contraindications Long-term goals The goal is not simply to move to a stronger medication

The most effective treatment plan depends on the individual